Before you sell to, join or invest in GelMEDIX, Inc.
MentionFox check on GelMEDIX, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/gelmedix-inc-form-d-25000002
Check GelMEDIX, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
GelMEDIX, Inc. filed a Form D with the Securities and Exchange Commission on 2025-02-04.
GelMEDIX, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 4, 2025. The filing reports $1M sold. Its industry group is Biotechnology. It names Max Cotler (Executive Officer), Nasim Annabi (Director), Reza Dana (Director) (SEC Form D, February 4, 2025).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like GelMEDIX, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-02-04 · the record
Pitching, partnering or investing alongside them? See who really runs and owns GelMEDIX, Inc.
Free to see. No signup.
Get an email when GelMEDIX, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when GelMEDIX, Inc. raises, hires or launches. No email unless you switch it on.
Watch GelMEDIX, Inc. →Get the full cited report on GelMEDIX, Inc.
What the filing shows about GelMEDIX, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on GelMEDIX, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives GelMEDIX, Inc.'s address as 238 Main Street, Fifth Floor, Cambridge, MA 02142.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for GelMEDIX, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
GelMEDIX, Inc. is a registered filer with the SEC (CIK 1815624) and has filed since 2024-03-26. 5 filings are on record, the latest on 2026-04-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
GelMEDIX, Inc.'s Form D of 2025-02-04 names Max Cotler, Nasim Annabi, Reza Dana and 2 more as its officers, directors or promoters.
Its new offerings report $3.29M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
The proceeds are available to fund general working capital requirements; as of the date of this filing no detailed operating budget has been adopted; and no proceeds have been or are proposed to be used for payments of compensation.
Max Cotler is named as Executive Officer on the Form D that GelMEDIX, Inc. filed with the SEC on 4 February 2025, one of 5 people that filing names.
Nasim Annabi is named as Director on the Form D that GelMEDIX, Inc. filed with the SEC on 4 February 2025, one of 5 people that filing names.
Reza Dana is named as Director on the Form D that GelMEDIX, Inc. filed with the SEC on 4 February 2025, one of 5 people that filing names.
Michael Cima is named as Director on the Form D that GelMEDIX, Inc. filed with the SEC on 4 February 2025, one of 5 people that filing names.
Parinaz Motamedy is named as Director on the Form D that GelMEDIX, Inc. filed with the SEC on 4 February 2025, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2025-02-04 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about GelMEDIX, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on GelMEDIX, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GelMEDIX, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist GelMEDIX, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind GelMEDIX, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for GelMEDIX, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/gelmedix-inc-form-d-25000002